Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nations
Separately, Johnson & Johnson is demanding additional payment for unwanted shots, confidential documents show.
More results...
Separately, Johnson & Johnson is demanding additional payment for unwanted shots, confidential documents show.
As advisers to the Food and Drug Administration endorsed ending one era of the Covid vaccination campaign, they also grappled with its future.
A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.
Janssen Pharmaceuticals ended a global trial after independent experts determined the vaccine was not effective. But there are other possibilities in the pipeline, scientists said.